China SXT Pharmaceuticals (SXTC) Receivables - Net (2018 - 2026)
China SXT Pharmaceuticals' Receivables - Net was $931,567 in fiscal Q4 2026 (quarter ended Mar 31, 2026), down 28.4% from $1.3 million a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Receivables - Net (2018 - 2026) Analysis & Trends
From fiscal Q4 2018 onward, China SXT Pharmaceuticals has reported Receivables - Net for 17 quarters.
- Receivables - Net has now declined for five consecutive fiscal years, with a five-year compound annual growth rate of -27.0% (FY2021 to FY2026).
- In earlier fiscal years, Receivables - Net was $1.3 million in FY2025 (-1.0%), $1.31 million in FY2024 (-2.2%), $1.34 million in FY2023 (-59.7%) and $3.33 million in FY2022 (-26.0%).
- The fiscal Q4 2026 figure marks the lowest quarterly Receivables - Net in data going back to fiscal Q4 2018.
- Compared with a year earlier, Receivables - Net was higher in 1 of the last four quarters, with an average decline of 5.6%.
- The best year-over-year quarter for Receivables - Net over five years was fiscal Q2 2025 (growth of 26.9%); the worst was fiscal Q2 2024 (a decline of 67.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | China SXT Pharmaceuticals | 251.61 | -85.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 931,567.00 |
| Sep 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 3.33 Mn |
| Sep 30, 2021 | 4.16 Mn |
| Mar 31, 2021 | 4.51 Mn |
| Sep 30, 2020 | 5.58 Mn |
| Mar 31, 2020 | 3.82 Mn |
| Sep 30, 2019 | 4.57 Mn |
| Mar 31, 2019 | 4.18 Mn |
| Sep 30, 2018 | 3.89 Mn |
| Mar 31, 2018 | 2.60 Mn |
API Access
China SXT Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();